EU holding back approval for Indian-made AstraZeneca vaccine 'discriminatory', say experts

Experts say the decision of European Union regulators to hold back approval for Covishield, AstraZeneca's Covid-19 vaccine made in India, is discriminatory and unscientific.

After Dr. Ifeanyi Nsofor and his wife received two doses of AstraZeneca's coronavirus vaccine in Nigeria, they assumed they would be free to travel this summer to a European destination of their choice. They were wrong. I realise that a lot of Indians who have taken COVISHIELD are facing issues with travel to the E.U., I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries. The couple - and millions of other people vaccinated through a U.N.-backed effort - could find themselves barred from entering many European and other countries because those nations don't recognize the Indian-made version of the vaccine for travel.